Drug intelligence / Profile preview

polyethylene glycol + ascorbic acid + simethicone

Development stage
Unknown
Lead developer
Salix Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination drug consisting of polyethylene glycol (PEG), ascorbic acid (vitamin C), and simethicone. It is primarily used for bowel preparation before colonoscopy. Polyethylene glycol acts as an osmotic laxative by retaining water in the stool, resulting in softer stools and promoting bowel movements. Ascorbic acid enhances the laxative effect through its osmotic properties and also helps reduce the required volume of PEG solution. Simethicone is an antifoaming agent that reduces gas bubbles in the gastrointestinal tract, improving mucosal visibility during colonoscopy and reducing patient discomfort such as bloating or abdominal fullness[1][2][3][4]. The combination has been shown to provide superior bowel cleansing efficacy compared to PEG-ascorbic acid alone, with better patient tolerability and improved endoscopist satisfaction[1][2].

Other names
PEG-Asc plus simethiconePEG-Asc + simethiconepolyethylene glycol with ascorbic acid and simethicone
02

Targets

Intestinal gas–liquid interface

Beyond the preview

Go deeper on polyethylene glycol + ascorbic acid + simethicone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol + ascorbic acid + simethicone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call